Learn more about what’s on the agenda for Session II of the 2026 MDS Annual Meeting
The second session of the 2026 MDS Annual Meeting offers what attendees value most: real-world case discussion and original research that changes how we think about treatment.
On Thursday, March 26 in Denver, Session II will feature:
Clinical Case: A 63-Year-Old Woman with Unilateral Facial Swelling
Dr. Alexandra Gosh presents a diagnostic challenge, with expert panel discussion from Drs. Scott Elman, Kari Wanat, and Daniela Kroshinsky, moderated by Dr. Robert Micheletti
Penile Calciphylaxis Outcomes
Zoya Siddiqui shares findings from a retrospective case-control analysis examining risk factors, treatment approaches, and mortality
Rituximab Monotherapy vs. Combination Therapy in Pemphigus Vulgaris
Sarini Saksena presents new infection risk data to inform treatment decisions
Treatment Tightropes: Navigating Complex Decision-Making in Dermatomyositis
Dr. Katharina Shaw explores the nuances of managing this challenging autoimmune condition
This session blends diagnostic reasoning, evidence-based treatment updates, and practical decision-making—exactly what makes the MDS meeting essential for clinicians managing complex medical dermatology cases. Explore the full agenda here.
